Philip F. VonVoigtlander

Author

W.E. Upjohn Institute for Employment Research

Also Known As

P F VonVoigtlander, P F Vonvoigtlander, P. F. VONVOIGTLANDER, P. F. VonVoigtlander, P.F. VonVoigtlander, P.F. Vonvoigtlander, PHILIP F. VONVOIGTLANDER, Philip F Vonvoigtlander, Philip F. VonVoigtlander, Philip F. Vonvoigtlander

Publications

2.7K

Citations

H-Index

Concepts

All Affiliations

W.E. Upjohn Institute for Employment Research CNS Research (United States)University of Notre Dame

About

Philip F. VonVoigtlander is an author at W.E. Upjohn Institute for Employment Research specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	25	909
2	Natural Sciences	7	7	303
3	Social Sciences	6	6	142
4	Health Sciences	4	4	82
5	Anesthesia	3	3	65

Philip F. VonVoigtlander

Publications

2.6K

Citations

H-Index

Page 1

	Year	Citations
U-50,488: a selective and structurally novel non-Mu (kappa) opioid agonist. Philip F. VonVoigtlander, Robert A. Lahti, James H. Ludens Journal of Pharmacology and Experimental Therapeutics	1983	815
Properties of a selective kappa agonist, U-50,488H Robert A. Lahti, Philip F. VonVoigtlander, Craig L. Barsuhn Life Sciences Molecular PharmacologySelective Kappa AgonistFunctional SelectivityMedicineNon-peptide Ligand	1982	198
Increased sensitivity to dopaminergic agents after chronic neuroleptic treatment. Philip F. VonVoigtlander, Elizabeth G. Losey, Herman J. Triezenberg Journal of Pharmacology and Experimental Therapeutics	1975	162
Analgesic and mechanistic evaluation of spiradoline, a potent kappa opioid. Philip F. VonVoigtlander, R A Lewis Journal of Pharmacology and Experimental Therapeutics	1988	102
3-Phenyl-Substituted Imidazo[1,5-<i>a</i>]quinoxalin-4-ones and Imidazo[1,5-<i>a</i>]quinoxaline Ureas That Have High Affinity at the GABA<sub>A</sub>/Benzodiazepine Receptor Complex E. Jon Jacobsen, Lindsay S. Stelzer, Kenneth L. Belonga, Journal of Medicinal Chemistry Drug TargetPharmacotherapyChemical BiologyPharmaceutical ChemistryDrug Resistance	1996	91
Pharmacological characterization of U-101387, a dopamine D4 receptor selective antagonist. Kalpana Merchant, G.S. Gill, David W. Harris, Journal of Pharmacology and Experimental Therapeutics	1996	89
The use of salicylate hydroxylation to detect hydroxyl radical generation in ischemic and traumatic brain injury John S. Althaus, Paula K. Andrus, Carl M. Williams, Molecular and Chemical Neuropathology Traumatic Brain InjuryReperfusion InjuryMedicineRadical (Chemistry)Brain Injury	1993	84
Kappa opioid analgesia is dependent on serotonergic mechanisms. Philip F. VonVoigtlander, R A Lewis, Gary L. Neff Journal of Pharmacology and Experimental Therapeutics	1984	81
U-54494A: a unique anticonvulsant related to kappa opioid agonists. Philip F. VonVoigtlander, Edward D. Hall, Marlene Camacho Ochoa, Journal of Pharmacology and Experimental Therapeutics	1987	73
Thyroid hormonal modulation of the binding and activity of the GABAA receptor complex of brain Joseph V. Martin, Daniel B. Williams, RAINA FITZGERALD, Neuroscience	1996	68

Page 1